山东医药
山東醫藥
산동의약
SHANDONG MEDICAL JOURNAL
2014年
34期
18-20
,共3页
史淑红%李艳芳%高秀娟%刘首娟%李荣霞%李腾华
史淑紅%李豔芳%高秀娟%劉首娟%李榮霞%李騰華
사숙홍%리염방%고수연%류수연%리영하%리등화
子宫内膜异位症%血管生成%血管内皮生长因子%血管内皮生长因子可溶性受体
子宮內膜異位癥%血管生成%血管內皮生長因子%血管內皮生長因子可溶性受體
자궁내막이위증%혈관생성%혈관내피생장인자%혈관내피생장인자가용성수체
endometriosis%angiogenesis%vascular endothelial growth factor%vascular endothelial growth factor soluble receptor
目的:观察子宫内膜异位症患者异位、在位子宫内膜组织中VEGF、sflt-1 mRNA表达变化。方法收集46例子宫内膜异位症患者的异位子宫内膜组织46份为异位组,在位子宫内膜组织32份为在位组,另收集30例非子宫内膜异位症患者子宫内膜组织为对照组。采用实时荧光定量PCR法检测各组VEGF mRNA 、sFlt-1 mRNA,采用比较阈值法(2-△△Ct法)计算VEGF mRNA、sflt-1 mRNA相对表达量。结果在位组VEGF mRNA表达量明显高于对照组和异位组(P均<0.05),对照组VEGFmRNA表达量高于异位组(P<0.01);在位组内膜VEGF活性指数高于异位组和对照组( P<0.05),异位组VEGF活性指数高于对照组,但差异无统计学意义;对照组内膜sflt-1mRNA表达量高于在位组和异位组(P<0.05),在位组sflt-1mRNA表达量高于异位组(P<0.05)。结论子宫内膜异位症患者异位、在位子宫内膜组织中VEGF、sflt-1 mRNA表达异常。 sflt-1可能参与了子宫内膜异位症的发病过程。
目的:觀察子宮內膜異位癥患者異位、在位子宮內膜組織中VEGF、sflt-1 mRNA錶達變化。方法收集46例子宮內膜異位癥患者的異位子宮內膜組織46份為異位組,在位子宮內膜組織32份為在位組,另收集30例非子宮內膜異位癥患者子宮內膜組織為對照組。採用實時熒光定量PCR法檢測各組VEGF mRNA 、sFlt-1 mRNA,採用比較閾值法(2-△△Ct法)計算VEGF mRNA、sflt-1 mRNA相對錶達量。結果在位組VEGF mRNA錶達量明顯高于對照組和異位組(P均<0.05),對照組VEGFmRNA錶達量高于異位組(P<0.01);在位組內膜VEGF活性指數高于異位組和對照組( P<0.05),異位組VEGF活性指數高于對照組,但差異無統計學意義;對照組內膜sflt-1mRNA錶達量高于在位組和異位組(P<0.05),在位組sflt-1mRNA錶達量高于異位組(P<0.05)。結論子宮內膜異位癥患者異位、在位子宮內膜組織中VEGF、sflt-1 mRNA錶達異常。 sflt-1可能參與瞭子宮內膜異位癥的髮病過程。
목적:관찰자궁내막이위증환자이위、재위자궁내막조직중VEGF、sflt-1 mRNA표체변화。방법수집46례자궁내막이위증환자적이위자궁내막조직46빈위이위조,재위자궁내막조직32빈위재위조,령수집30례비자궁내막이위증환자자궁내막조직위대조조。채용실시형광정량PCR법검측각조VEGF mRNA 、sFlt-1 mRNA,채용비교역치법(2-△△Ct법)계산VEGF mRNA、sflt-1 mRNA상대표체량。결과재위조VEGF mRNA표체량명현고우대조조화이위조(P균<0.05),대조조VEGFmRNA표체량고우이위조(P<0.01);재위조내막VEGF활성지수고우이위조화대조조( P<0.05),이위조VEGF활성지수고우대조조,단차이무통계학의의;대조조내막sflt-1mRNA표체량고우재위조화이위조(P<0.05),재위조sflt-1mRNA표체량고우이위조(P<0.05)。결론자궁내막이위증환자이위、재위자궁내막조직중VEGF、sflt-1 mRNA표체이상。 sflt-1가능삼여료자궁내막이위증적발병과정。
Objective To explore the expression of vascular endothelial growth factor( VEGF) and vascular endotheli-al growth factor soluble receptor-1( sflt-1) in endometriosis patients'ectopic endometrial tissue and eutopic endometrial tis-sue.Methods Forty-six parts of ectopic endometrial tissue of ectopic group were collected in 46 patients with endometrio-sis, thirty-two parts of eutopic endometrial tissue were involved as eutopic group.Thirty parts of endometrial tissue in non-endometriosis patients were collected as control group.VEGF and sflt-1 mRNA were detected by Real-time quantitative PCR assay, the expression levels were calculated using the difference threshold algorithm.Result Expression of VEGF mRNA and VEGF activity index in eutopic group were higher than those of ectopic group and control group( all P<0.05) . Expression of VEGF mRNA in control group was higher than ectopic group(P<0.01).Expression of sflt-1 in control group was higher than eutopic group and ectopic group, which in eutopic group was higher than ectopic group(all P<0.05). Conclusions There are changes with expression of VEGF and sflt-1 in endometriosis patients'ectopic endometrial tissue and eutopic endometrial tissue.sflt-1 may be related to the pathogenesis of endometriosis.